In our previous work, we employed scRNA-Seq to explore the transcriptomic profiling in clinical MPN samples and identified S100A8 as one of several differentially expressed genes between JAK2- and CALR-mutated patients [21]. Here, S100A8 is linked to myeloproliferative neoplasm.